Summary by Moomoo AI
KEYSTONE PHARMACEUTICAL-B (THE “COMPANY”) ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON WEDNESDAY, MARCH 27, 2024 FOR THE PURPOSE OF CONSIDERING AND APPROVING AND PUBLISHING THE ANNUAL RESULTS OF THE COMPANY AND ITS SUBSIDIARIES FOR THE YEAR ENDED DECEMBER 31, 2023. The meeting will be chaired by the Company's Chairman and Non-Executive Director, Dr. Li Wai, and other Board members will include Executive Director Dr. Yang Jianxin, Non-Executive Director Mr. Kenneth Walton Hitchner III, Mr. Lin Xianghong and Mr. Hu Zhengguo, as well as Independent Non-Executive Directors Dr. Paul Herbert Chew, Mr. Wu Ding Xu and Mr. Sun Hung Bin. The meeting will provide investors with an updated overview of the company's financial performance.